Influence of strontium on bone mineral density and bone mineral content measurements by dual X-ray absorptiometry

Citation
Sp. Nielsen et al., Influence of strontium on bone mineral density and bone mineral content measurements by dual X-ray absorptiometry, J CLIN DENS, 2(4), 1999, pp. 371-379
Citations number
11
Categorie Soggetti
Endocrynology, Metabolism & Nutrition
Journal title
JOURNAL OF CLINICAL DENSITOMETRY
ISSN journal
10946950 → ACNP
Volume
2
Issue
4
Year of publication
1999
Pages
371 - 379
Database
ISI
SICI code
1094-6950(199924)2:4<371:IOSOBM>2.0.ZU;2-9
Abstract
The presence of Sr in bone influences bone mineral density (BMD) and bone m ineral content (BMC) measurements by dual X-ray absorptiometry (DXA). This interaction is of interest, since strontium ranelate (S12911) demonstrated positive effects on bone metabolism in various animal models of osteoporosi s, and is currently being evaluated for treatment of postmenopausal osteopo rosis. The present in vitro study aimed to determine adjustment factors for DXA measurements of BMC and BMD at different Sr concentrations in order to estimate the corresponding values that would have been measured without Sr . A series of mixtures of Ca and Sr hydroxyapatites were prepared, with bio logically relevant Sr/Ca ratios ranging from 0 to 3.5 mol/mol%, and a const ant total concentration of divalent cations (145 mmol). The mixtures were c onditioned in plastic dishes 4.5 cm in diameter, to obtain an areal density close to the human vertebral mineral density of 0.7-1.1 g/cm(2). DXA measu rements of the mixtures were made with a wide range of different instrument s and various acquisition modes. A direct linear relationship (r(2) > 0.99) was found between Sr content and overestimation of BMD and BMC, There were no significant differences in adjustment factors for BMC or BMD between th e different machines or acquisition modes, and the presence of Sr in the wa ter bath used to mimic soft tissues did not affect the accuracy and precisi on of the method. This demonstrates that reliable DXA determinations of BMD may be carried out in the presence of Sr, and may be interpreted in terms of calcium hydroxyapatite equivalent if the bone Sr content of the measured bone is known. The same adjustment factor (10% overestimation for 1 mol/mo l% Sr) can be used for all presently available types of instrument and acqu isition modes.